The DOI matches its Crossref record; 113 of the 116 references it cites were found in a registry or an index.
Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials
Open accessAbstract
Objective: It is unclear whether blockade of the angiotensin system has effects on mental health. Our objective was to determine the impact of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor (AT1R) blockers on mental health domain of quality of life. Study design: Meta-analysis of published literature. Data sources: PubMed and clinicaltrials.gov databases. The last search was conducted in January 2017. Study selection: Randomized controlled trials comparing any angiotensin converting enzyme inhibitor or AT1R blocker versus placebo or non-angiotensin converting enzyme inhibitor or non-AT1R blocker were selected. Study participants were adults without any major physical symptoms. We adhered to meta-analysis reporting methods as per PRISMA and the Cochrane Collaboration. Data synthesis: Eleven studies were included in the analysis. When compared with placebo or other antihypertensive medications, AT1R blockers and angiotensin converting enzyme inhibitors were associated with improved overall quality of life (standard mean difference = 0.11, 95% confidence interval = [0.08, 0.14], p < 0.0001), positive wellbeing (standard mean difference = 0.11, 95% confidence interval = [0.05, 0.17], p < 0.0001), mental (standard mean difference = 0.15, 95% confidence interval = [0.06, 0.25], p < 0.0001), and anxiety (standard mean difference = 0.08, 95% confidence interval = [0.01, 0.16], p < 0.0001) domains of QoL. No significant difference was found for the depression domain (standard mean difference = 0.05, 95% confidence interval = [0.02, 0.12], p = 0.15). Conclusions: Use of angiotensin blockers and inhibitors for the treatment of hypertension in otherwise healthy adults is associated with improved mental health domains of quality of life. Mental health quality of life was a secondary outcome in the included studies. Research specifically designed to analyse the usefulness of drugs that block the angiotensin system is necessary to properly evaluate this novel psychiatric target.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lithium and divalproex are also associated with weight gain.791”
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · cited 2×
“We analysed the funnel plot graph for verifying publication bias, which is a scatter plot of the SMD against a measure of study size, calculated the Egger test (Egger et al., 1997; Soeken and Sripusanapan, 2003) and employed the Orwin’s fail-safe N test to quantify the number of possible negative omitted studies that…”
Method(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
Kushner (2021) · doi:10.12788/jfp · Cited by 3,799
Quantitative Synthesis in Systematic Reviews
Lau, J., Ioannidis, J. P. A., & Schmid, C. H. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-9-199711010-00008 · Cited by 2,517
Imputing missing standard deviations in meta-analyses can provide accurate results
Furukawa, T. A., Barbui, C., Cipriani, A., Brambilla, P., & Watanabe, N. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.06.006 · Cited by 1,568 · cited 1×
“For trials that did not report SD or other dispersion measure, the SD of similar trials was imputed to ensure standardizing constants were comparable across trials as per the method of Furukawa (Furukawa et al., 2006).”
MethodAndrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416 · cited 1×
“The evidence was assessed and ranked according to the grading of recommendations assessment, development and evaluation (GRADE) for high risk of bias, imprecision, indirectness, heterogeneity and publication bias (Andrews et al., 2013).”
MethodThe Effects of Antihypertensive Therapy on the Quality of Life
Croog, S. H., Levine, S., Testa, M. A., Brown, B., Bulpitt, C. J., Jenkins, C. D., Klerman, G. L., & Williams, G. H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606263142602 · Cited by 1,325 · cited 2×
“Twenty studies did not use a validated scale for measuring QoL and were hence excluded (Bracchetti et al., 1990; Conlin et al., 1998; Croog et al., 1986; Ebert and Kirch, 1999; Fagher et al., 1991; Fletcher et al., 1992; Freytag et al., 2001; Hu and Zhu, 1999; Lacourciere, 1988; Lewis et al., 1996; McMahon et al., 199…”
Method
Research works printed but not linked: 5
- Carre A, Petetin N, Jouvent R, et al. (1988) Blood pressure control and quality of life: A comparative multicenter double-blind and cross-over trial of labetalol and captopril. La Revue de Médecine Interne 9: 545–553.
- Higgins JPT, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. London: The Cochrane Collaboration.
- Jp H (2011) Handbook for Systematic Reviews of Interventions Version 5.1.0. London: The Cochrane Collaboration.
- 10.1001/jama.1993.03510060059034 · DOI · Paper page
- Os I, Bratland B, Dahlof B, et al. (1991) Lisinopril and nifedipine in essential hypertension: A Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients. Journal of Hypertension 9: S382–S383.
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationGoldstein, B. I., Baune, B. T., Bond, D. J., Chen, P., Eyler, L. T., Fagiolini, A. M., Gomes, F. A., Hájek, T., Hatch, J. K., McElroy, S. L., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.12921 · Cited by 121
Antihypertensive Drugs and Risk of Depression: A Nationwide Population-Based Study
Kessing, L. V., Rytgaard, H. C. W., Ekstrøm, C. T., Torp-Pedersen, C. T., Berk, M., & Gerds, T. A. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15605 · Cited by 107
“Use of ACE inhibitors and ARBs for the treatment of hypertension in otherwise healthy adults has been associated with improved mental health domains of quality of life.(21) There are no randomized clinical trials of angiotensin agents and depression.”
MethodSelf-citationCarnovale, C., Perrotta, C., Baldelli, S., Cattaneo, D., Montrasio, C., Barbieri, S. S., Pompilio, G., Vantaggiato, C., Clementi, E., & Pozzi, M. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac110 · Cited by 70
“ther placebo or non-ACEI or non-ARBs, the use of ACEI or ARBs was significantly associated with improved mental health domains in adults (overall quality of life, positive wellbeing, mental and anxiety domains of quality of life).(104) Noteworthy, in a recent 12-week randomized, double-blind, placebocontrolled study,…”
ResultRole of brain renin–angiotensin system in depression: A new perspective
Ali, N. H., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Hamad, R. S., Alexiou, A. T., Papadakis, M., Saad, H. M., & Batiha, G. E. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14525 · Cited by 55
“103 It has been shown that ACEIs and ARBs reduce the use of antidepressant drugs in hypertensive patients with depression.”
Background
Metadata
- Authors
- Brownstein, D. J., Salagre, E., Köhler, C., Stubbs, B., Vian, J., Pereira, C., Chavarria, V., Karmakar, C., Turner, A., Quevedo, J., Carvalho, A. F., Berk, M., & Fernandes, B. S.
- Affiliations
- Monash University (AU)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Universidade Federal do Ceará (BR)
- King's College London (GB)
- University of Lisbon (PT)
- Parc de Salut (ES)
- Deakin University (AU)
- Barwon Health (AU)
- The University of Texas MD Anderson Cancer Center (US)
- Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil
- Universidade Federal do Rio Grande do Sul (BR)
- Corresponding author
- Fernandes, Brisa S
- ORCID
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2017-07-28
- Volume
- 52
- Issue
- 1
- Pages
- 24-38
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2740997385
- Cited by
- 46
- References
- 116
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 2 · 2023: 6 · 2022: 10 · 2021: 4 · 2020: 8 · 2019: 1 · 2018: 5
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Australian & New Zealand Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Own your potential (DEAKIN) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Funders
- National Institute for Health and Care Research (ICA-CL-2017-03-001, NIHR-INF-0685)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- ACE inhibitors, angiotensin receptor blockers, quality of life, mental health, well-being, anxiety, depression, hypertension, antihypertensive drugs, psychiatric adverse effects
- MeSH terms
- Angiotensin-Converting Enzyme Inhibitors, Anxiety, Humans, Hypertension, Mental Health, Quality of Life, Randomized Controlled Trials as Topic, Angiotensin II Type 1 Receptor Blockers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials. https://app.cochat.ai/papers/10.1177/0004867417721654
- The paper
- Brownstein, D. J., Salagre, E., Köhler, C., Stubbs, B., Vian, J., Pereira, C., Chavarria, V., Karmakar, C., Turner, A., Quevedo, J., Carvalho, A. F., Berk, M., & Fernandes, B. S. (2018). Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867417721654
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.